Clinical trials
Phase 1/2 Carcinoma, Renal Cell trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inhibrx Biosciences, Inc | 1 |
| Kymab Limited | 1 |
| NGM Biopharmaceuticals, Inc | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 4 |
| Carcinoma, Renal Cell | 4 |
| Melanoma | 4 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Stomach Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.